CNTX icon

Context Therapeutics
CNTX

Overview Fund Activity

24 hedge funds and large institutions have $4.59M invested in Context Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Holders
24
Holders Change
+4
Holders Change %
+20%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$145K
2
ACM
2
AIGH Capital Management
Maryland
$1.43M
3
Jane Street
3
Jane Street
New York
$80K
4
Two Sigma Investments
4
Two Sigma Investments
New York
$63K
5
QC
5
Quadrature Capital
United Kingdom
$51K

Top Sellers

1
VF
1
Virtu Financial
New York
$0
2
AWS
2
Atria Wealth Solutions
New York
$0
3
UBS Group
3
UBS Group
Switzerland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$0 100 – –
RG
27
Retirement Group
California
$0 155 – –
Wells Fargo
28
Wells Fargo
California
$0 99 +30 +43%
1
2